Publications by authors named "Michael Augustyniak"

Claim this Profile
M
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Joseph Kovalchin, Jeffrey Krieger, Michelle Genova, Norio Kawamoto, Michael Augustyniak

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers.
Joseph Kovalchin, Jeffrey Krieger, Kathy Collins, Michelle Genova, Michael Augustyniak

J Clin Pharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donors.
Shiow-Jyi Wey, Michael E Augustyniak, Edward D Cochran, James L Ellis, Xinqin Fang

J Med Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.
James L Ellis, Michael E Augustyniak, Edward D Cochran, Richard A Earl, David S Garvey

Inflammopharmacology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs.
Ramani R Ranatunge, Michael E Augustyniak, Vijay Dhawan, James L Ellis, David S Garvey

Bioorg Med Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings?
Hector Vila, Robert A Smith, Michael J Augustyniak, Peter A Nagi, Roy G Soto

Anesth Analg· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.
Subhash P Khanapure, Michael E Augustyniak, Richard A Earl, David S Garvey, L Gordon Letts

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
Ramani R Ranatunge, Michael Augustyniak, Upul K Bandarage, Richard A Earl, James L Ellis

J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis